Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2014
11/20/2014US20140343141 Topical composition comprising an ingenol derivative and a surfactant-cosolvent mixture
11/20/2014US20140343140 Agent for Preventing and/or Treating Veisalgia
11/20/2014US20140343136 Phytocannabinoids for use in the treatment of intestinal inflammatory diseases
11/20/2014US20140343135 Method for obtaining an extract rich in ellagic acid tannins from fruits that contain these compounds, and resulting extract
11/20/2014US20140343134 Ellagitannins Rich Extracts Composition in Sexual Wellness
11/20/2014US20140343128 Combination of a phosphoinositide 3-kinase inhibitor and a modulator of the Janus Kinase 2 - Signal Transducer and Activator of Transcription 5 pathway
11/20/2014US20140343125 Oligonucleotides for rna interference and biological applications thereof
11/20/2014US20140343124 Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas
11/20/2014US20140343120 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
11/20/2014US20140343119 4-hydroxybutyric acid analogs
11/20/2014US20140343118 Methods of treatment using arylcyclopropylamine compounds
11/20/2014US20140343117 Methods and products to diagnose and treat heatiness
11/20/2014US20140343116 Cytochrome p450 2c9 inhibitors
11/20/2014US20140343115 Ropinirole-Containing Adhesive Patch
11/20/2014US20140343112 Use of amino acid supplementation for improved muscle recovery
11/20/2014US20140343111 Diarylthiohydantoin compounds
11/20/2014US20140343109 PHARMACEUTICAL CONTAINING PPAR-delta AGONIST
11/20/2014US20140343107 Formulations and uses of retinoic acid receptor selective agonists
11/20/2014US20140343105 Novel orally administered dabigatran formulation
11/20/2014US20140343104 Osteogenesis promoter and use thereof
11/20/2014US20140343102 Crystalline forms of the sodium salt of (4--cyclohexyl)-acetic acid
11/20/2014US20140343101 Small molecule modulators of epigenetic regulation and their therapeutic applications
11/20/2014US20140343100 Sublingual fentanyl spray
11/20/2014US20140343099 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/20/2014US20140343098 Modulators of atp-binding cassette transporters
11/20/2014US20140343097 5-(2-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one for the treatment of lung function
11/20/2014US20140343094 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/20/2014US20140343092 Pyrrolopyridinone Compounds And Methods For Treating HIV
11/20/2014US20140343091 Beta2-adrenoceptor agonists
11/20/2014US20140343086 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/20/2014US20140343080 Drug-containing implants and methods of use thereof
11/20/2014US20140343078 Compositions and methods for inhibiting cytochrome p450 2d6
11/20/2014US20140343077 Hepatitis c inhibitor compounds
11/20/2014US20140343076 Pharmaceutical compositions of lurasidone
11/20/2014US20140343075 Piperidine and piperazine derivatives as autotaxin inhibitors
11/20/2014US20140343072 Orally dispersible tablet containing compacted sildenafil base
11/20/2014US20140343071 Compositions and methods for treating cancer
11/20/2014US20140343069 Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
11/20/2014US20140343068 Certain chemical entities, compositions, and methods
11/20/2014US20140343067 Method of Reducing Facial Flushing Associated with Systemic Use of Phosphodiesterase Type 5 Inhibitors
11/20/2014US20140343063 Method of treating a viral infection using elvitegravir combinations
11/20/2014US20140343062 Method of treating a viral infection using elvitegravir combinations
11/20/2014US20140343060 Aprepitant l-proline solvates - compositions and cocrystals
11/20/2014US20140343058 Treatment of systemic lupus erythematosus
11/20/2014US20140343057 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
11/20/2014US20140343051 Methods to modulate acute myeloid leukemia stem/progenitor cell expansion and/or differentiation
11/20/2014US20140343046 Use of selective gaba a alpha 5 negative allosteric modulators for the treatment of central nervous system conditions
11/20/2014US20140343045 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
11/20/2014US20140343044 Method for the treatment of dravet syndrome
11/20/2014US20140343043 Composition
11/20/2014US20140343041 Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache
11/20/2014US20140343037 Benzene, pyridine, and pyridazine derivatives
11/20/2014US20140343034 Skin barrier function improving agent
11/20/2014US20140343033 Azaindole derivatives
11/20/2014US20140343029 Novel Imidazole Amines as Modulators of Kinase Activity
11/20/2014US20140343028 Methods of treating oral mucositis
11/20/2014US20140343027 Edible oils to enhance delivery of orally administered steroids
11/20/2014US20140343026 Dosage Form to Increase Prasterone Bioavailability
11/20/2014US20140343025 Pharmaceutical composition
11/20/2014US20140343023 Ror gamma modulators
11/20/2014US20140343022 Progesterone Antagonists such as CDB-4124 in the Treatment of Breast Cancer
11/20/2014US20140343021 Adjuvant to thrombolytic therapy for the treatment of frostbite
11/20/2014US20140343020 Methods of using substituted tetracycline compounds to modulate rna
11/20/2014US20140343014 Combination of a certain dpp-4 inhibitor and voglibose
11/20/2014US20140343013 Stabalized Glycosaminoglycan Preparations and Related Methods
11/20/2014US20140343012 Compositions and methods for treating joints
11/20/2014US20140343011 Methods for treating or preventing urological inflammation
11/20/2014US20140343010 Co-crystals of dapagliflozin
11/20/2014US20140343009 Methods for treating methylmalonic acidemia
11/20/2014US20140343008 Hepatitis c treatment
11/20/2014US20140343007 Combination Therapy Using Ribavirin As EIF4E Inhibitor
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140343005 Aqueous compositions comprising arbekacin
11/20/2014US20140343004 Compositions for Oral Administration to Animals, Processes for Obtaining the Same and the Uses Thereof
11/20/2014US20140343003 Method for treating lyme disease
11/20/2014US20140343002 Method of lowering glycemic index of foods
11/20/2014US20140343000 Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
11/20/2014US20140342999 Compounds for treating proliferative disorders
11/20/2014US20140342998 Quinone based nitric oxide donating compounds
11/20/2014US20140342989 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
11/20/2014US20140342986 Compositions and methods for treating diseases
11/20/2014US20140342975 Therapeutic Process For The Treatment Of The Metabolic Syndrome And Associated Metabolic Disorders
11/20/2014US20140342048 Sauces, spreads, cooking oils, and cooking fats made from various ingredients
11/20/2014US20140342042 Method of lowering glycemic index of foods
11/20/2014US20140342024 Compositions for topical treatment
11/20/2014US20140342023 Composition for use in the prevention and treatment of cardiovascular diseases
11/20/2014US20140342022 Natural Product Against Fatigue
11/20/2014US20140342021 Magnesium compositions and uses thereof for neurological disorders
11/20/2014US20140342018 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
11/20/2014US20140342010 Use of foti to enhance stem cell mobilization and proliferation
11/20/2014US20140342009 Boswellia oil, its fractions and compositions for enhancing brain function
11/20/2014US20140342003 Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
11/20/2014US20140342002 Particulate materials
11/20/2014US20140342001 Medicaments
11/20/2014US20140341999 Antitubercular composition and method for producing same
11/20/2014US20140341998 Pharmaceutical composition for inhalation
11/20/2014US20140341996 Nanoengineering of Functionalized Polymers and Its Manufacturing and Formulation Methods for Personalized Cancer Therapies
11/20/2014US20140341994 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
11/20/2014US20140341993 Solid pharmaceutical composition comprising an antibiotic from the quinolone family and method of production thereof
11/20/2014US20140341992 Compositions of imatinib
1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 7860